Abstract
Screening for cancer has been and remains the subject of worldwide study, analysis, and scrutiny. The philosophy — which is based upon early detection, diagnosis, and treatment — of interrupting the spread of disease before it becomes advanced carries with it broad implications for society. For diseases such as cervical and breast cancer, primary prevention cannot be applied, since the causes are not known, and, in the case of breast cancer, it is very likely that there are multiple causes. For these malignancies, screening tests are applied to improve survival and achieve mortality reduction. Breast cancer is considered suitable for screening because of (a) the potential for serious morbidity and high mortality, (b) the fact that there is a detectable preclinical phase, (c) the established effectiveness of early treatment, and (d) the high prevalence among the screened population. From a practical point of view, however, breast cancer screening requires the examination of large numbers of healthy women in order to designate for more thorough assessment the small proportion that will likely be diagnosed with breast cancer Richert-Boe and Humphrey 1992). It is understandable, therefore, because of the economic consequences of such wide-scale screening and the physical implications of the screening and diagnostic tests, that there should be intensive scrutiny both of the test itself and of its effect on the population.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
American Cancer Society (1990) 1989 survey of physicians’ attitudes and practices in early cancer detection. CA Cancer J Clin 40:77
Austoker J (1991) Organisation of a national screening programme. Br Med Bull 47: 416–426
Baker LH (1982) Breast Cancer Detection Demonstration Project: five year summary report. CA Cancer J Clin 32: 194–226
Beahrs LH, Shapiro S, Smart C (1979) Report of the working group to review the National Cancer Institute–American Cancer Society Breast Cancer Detection Demonstration Projects. J Natl Cancer Inst 62: 640–709
Bird RE (1989) Low cost screening mammography: report on finances and review of 21 716 consecutive cases. Radiology 171: 87–90
Bird RE, McLelland R (1986) How to initiate and operate a low cost screening mammography center. Radiology 161: 43–47
Bjurstam N, Bjorneld L (1994) Mammography screening in women aged 40–49 years at entry: results of the randomized controlled trial in Gothenburg, Sweden. Syllabus, 26th National Conference on Breast Cancer. American College of Radiology, Reston, VA, p 101
Burhenne HJ (1993) Screening mammography in British Columbia. Roentgenpraxis (Germany) 46: 367–370
Burhenne HI, Warren Burhenne L, Goldberg F et al. (1994) Interval breast cancers in the screening mammography program of British Columbia: analysis and classification. AJR 162: 1067–1071
Canadian Cancer Statistics, Statistics Canada (1993) Health & Welfare Canada, pp 55–65
Chamberlain J, Moss SM, Kirkpatrick AE (1993) National health service breast screening programme results for 1991–2. BMJ 307: 353–356
Collette HJA, Day NE, Rombach JJ et al. (1984) Evaluation of screening for breast cancer in a non-randomized study (the DOM Project) by means of a case-control study. Lancet 1: 1224–1226
DeBruhl ND, Bassett LW, Jessop NW et al. (1994) Mobile mammography: results of national survey. Radiological Society of North America, Chicago, Ill., p 217
de Koning HJ, van Ineveld BM, van Oortmarssen GJ et al. (1991) Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors. Int J Cancer 49: 531–537
Eckhardt S, Badellino F, Murphy GP (1995) UICC meeting on breast cancer screening in premenopausal women in developed countries. UICC News IV, 4 December 1995
Elwood JM, Cox B, Richardson AK (1993) Effectiveness of breast cancer screening by mammography in younger women. J Curr Clin Trials 3L: 32
Feig SA (1994) Determiniation of mammographic screening intervals with surrogate measures for women aged 40–49 years. Radiology 193: 311–314
Feig SA, Hendrick RE (1994) Risk, benefit, and controversies in mammographic screening. RSNA Categorical Course in Physics, pp 121–137
Fletcher SW, Black W, Harris R et al. (1993) Report of the international workshop on screening for breast cancer. J Natl Cancer Inst 85: 1644–1656
Fox S, Baum JK, Klos DS et al. (1985) Breast cancer screening: the underuse of mammography. Radiology 156: 607–611
Fox SA, Murata PJ, Stein JA (1991) The impact of physician compliance on screening mammography for older women. Arch Intern Med 151: 50–56
Frisell J, Eklund G, Hellstrom L et al. (1987) Analysis of interval breast carcinomas in a randomized screening trial in Stockholm. Breast Cancer Res Treat 9: 219–225
Gambhir S, Bassett LW (1991) The underutilization of screening mammography: overcoming the barriers. J Prim Care Cancer, October 1991, pp 27–33
Garfinkel LE (1994) Evaluating cancer statistics. CA Cancer J Clin 44: 5–6
Hakama M, Elovainio L, Kajantie R et al. (1991) Breast cancer screening as public health policy in Finland. 64: 962–964
Hayward RA, Shapiro MF, Freeman HE et al. (1988) Who gets screened for cervical breast cancer? Arch Intern Med 148: 1177–1181
Hillman BJ (1994) Outcomes research and cost-effectiveness analysis for diagnostic imaging. Radiology 193: 307–310
Klemi PJ, Joensuu H, Toikkanen S et al. (1992) Aggressiveness of breast cancers found with and without screening. BMJ 304: 467–469
Kopans DB (1994) Conventional wisdom: observation, experience, anecdote, and science in breast imaging. AJR 162: 299–303
Kopans DB, Halpern E, Hulka CA (1994) Statistical power in breast cancer screening trials and mortality reduction among women 40–49 years of age with particular emphasis on the National Breast Screening Study of Canada. Cancer 74: 1196–1203
Kron ES, Moskowitz H, McConner D et al. (1989) Mobile mammography: the first six-months experience at Mount Sinai Hospital. Conn Med 53: 71–72
Letton AH, Mason EM (1989) Routine breast screening for cancer. Semin Surg Oncol 5: 163–167
Mandelblatt JS, Fahs MC (1988) The cost-effectiveness of cervical cancer screening for low-income elderly women. JAMA 259: 2409–2413
Mettlin C, Smart CR (1994) Breast cancer detection guidelines for women aged 40 to 49 years: rationale for the American Cancer Society reaffirmation of recommendations. CA Cancer J Clin 44: 248–255
Moskowitz M (1987) Costs of screening for breast cancer. Radiol Clin North Am 25: 1031–1037
Mushlin AI, Fintor L (1992) Is screening for breast cancer cost-effective? Cancer 69: 1956–1962
National Board of Health and Welfare (1990) Official recommendations from the National Board of Health and Welfare. Mammographic screening for early detection of breast cancer. Socialstyrelsen, Stockholm, Sweden
Nystrom L, Rutqvist LE, Wall S et al. (1993) Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 341: 973–978
Palli D, Del Turco MR, Buiatti E et al. (1986) A case-control study of the efficiency of a non-randomized breast cancer screening program in Florence, Italy. Int J Cancer 38: 501–504
Pamilo M, Anttinen I, Soiva M et al. (1990) Mammography screening–reasons for recall and the influence of experience on recall in the Finnish system. Clin Radiol 41: 384–387
Peeters PHM, Verbeek ALM, Hendriks JHCL et al. (1989) Screening for breast cancer in Nihmegen. Report of 6 screening rounds, 1975–1986. Int J Cancer 43: 226–230
Richert-Boe KE, Humphrey LL (1992) Screening for cancers of the cervix and breast. Arch Intern Med 152: 2405–2411
Richards MT (1994) Australian experience of mammographic screening. In: Tan L, Siew E (eds) Handbook for the 18th International Congress of Radiology, Singapore. Continental Press, p 787
Rimer BK, Kasper Keintz M, Kessler HB et al. (1989) Why women resist screening mammography: patient-related barriers. Radiology 172: 243–246
Roberts MM, Alexander FE, Anderson TJ et al. (1990) Edinburgh Trial of Screening for Breast Cancer: mortality at seven years. Lancet I: 241–246
Rosenquist CJ, Lindfors KK (1994) Screening mammography in women aged 40–49 years: analysis of cost-effectiveness. Radiology 191: 647–650
Rubin E, Frank M, Stanley R et al. (1990) Patient initiated mobile mammography: analysis of the patients and the problems. South Med J 83: 178–184
Rutqvist LE, Miller AB, Andersson I et al. (1990) Reduced breast cancer mortality with mammography screening–an assessment of currently available data. Int J Cancer 5: 76–84
Schwartz RM, Rollins PL (1985) Measuring the cost benefit of wellness strategies. Business Health, October, 24–26
Schofield PE, Cockburn J, Hill DJ et al. (1994) Encouraging attendance at a screening mammography programme: determinants of response to different recruitment strategies. J Med Screen 1: 144–149
Seidman H, Gelb SK, Silverberg E (1987) Survival experience in the Breast Cancer Detection Demonstration Project. CA Cancer J Clin 37: 258–290
Shapiro S (1977) Evidence of screening for breast cancer from a randomized trial. Cancer 39:2722–2782
Shapiro S, Venet W, Strax P et al. (1982) Ten-to-fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst 69: 349–355
Shapiro S, Venet W, Strax P et al. (1988) Periodic screening for breast cancer: the Health Insurance Plan Project and its sequelae. Johns Hopkins University Press, Baltimore, pp 1963–1986
Sickles EA (1988) Impact of low cost mammography screening on nearby mammography practices. Radiology 168: 59–61
Sickles EA, Kopans DB (1993) Deficiencies in the analysis of breast cancer screening data. J Natl Cancer Inst 85: 1621–1624
Sickles EA, Weber W, Galvin HB et al. (1986) Mammographic screening: how to operate successfully at low cost. Radiology 160: 95–97
Sickles EA, Ominsky SH, Sollitto RA et al. (1990) Medical audit of a rapid throughput mammography screening practice: methodology and results of 27114 examinations. Radiology 175: 323–327
Smart CR, Hendrick RE, Rutledge JH III, Smith RA (1995) Benefit of mammography screening in women ages 40 to 49 years: current evidence from randomized controlled trials. Cancer 75: 1619–1626
Stange PV, Sumner AT (1978) Predicting treatment costs and life expectancy for end-stage renal disease. N Engl J Med 298: 372–378
Strax P, Venet L, Shapiro S (1973) Value of mammography in reduction of mortality from breast cancer in mass screening. AJR 117: 686–689
Tabar L, Dean PB (1989) The present state of screening for breast cancer. Semin Surg Oncol 5: 94–101
Tabar L, Fagerberg G, Eklund G (1985a) Reduction in breast cancer mortality by mass screening with mammography: first results of randomized trial in two Swedish counties. Lancet 1: 829–832
Tabar L, Gad A, Holmberg L et al. (1985b) Significant reduction in advanced breast cancer: results of the first seven years of mammography screening in Kopparberg, Sweden. Diagn Imaging Clin Med 54: 158–164
Tabar L, Fagerberg G, Duffy SW et al. (1992) Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 30: 187–210
The Essendon Breast X-ray Program Collaborative Group (1992) A mammographic screening pilot project in Victoria 1988–1990. Med J Aust 157: 670–675
The NCI Breast Cancer Screening Consortium (1990) Screening mammography: a missed clinical opportunity? JAMA 264: 54–58
Thurfjell EL, Lindgren AA (1994) Population-based mammography screening in Swedish clinical practice: prevalence and incidence screening in Uppsala County. Radiology 193: 351–357
Turner KM, Wilson BJ, Gilbert FJ (1994) Improving breast screening uptake: persuading initial non-attenders to attend. J Med Screen 1: 199–202
UK Trial of Early Detection of Breast Cancer Group (1988) First resuls on mortality reduction in the UK trial of early detection of breast cancer. Lancet II: 411–416
UK Trial of Early Detection of Breast Cancer Group (1992) Specificity of screening in United Kingdom trial of early detection of breast cancer. BMJ 304: 346–349
UK Trial of Early Detection of Breast Cancer Group (1993) Breast cancer mortality after 10 years in the UK trial of early detection of breast cancer. The Breast 2: 13–20
van der Maas, de Koning HJ, van Ineveld BM et al. (1989) The cost-effectiveness of breast cancer screening. Int J Cancer 43: 1055–1060
van Dijck JAAM, Verbeek ALM, Hendriks JHCL et al. (1993) The current detectability of breast cancer in a mammographic screening program. Cancer 72: 1993–1938
van Ineveld BM, van Oortmarssen GJ, de Koning HJ et al. (1993) How cost-effective is breast cancer screening in different EC countries? Eur J Cancer 29A: 1663–1668
Verbeek ALM, Hwnseika JHCL, Holland R et al. (1984) Reduction of breast cancer mortality through mass screening with modern mammography: first results of the Nijmegen Project. Lancet 1: 1222–1224
Vogel VG, Graves DS, Coody DK et al. (1990) Breast screening compliance following a statewide low-cost mammography project. Cancer Detect Prey 14: 573–576
Wald N, Chamberlain J, Hackshaw A (1993) Report of the European society of mastology breast cancer screening evaluation committee. Tumori 79: 371–379
Warren Burhenne LJ (1994)
Warren Burhenne LJ, Hislop TG, Burhenne HJ (1992a) The British Columbia mammography screening program: evaluation of the first 15 months. AJR 158: 45–49
Warren Burhenne LJ, Burhenne HJ, Hislop TG (1992b) Result-oriented mass mammography screening. RSNA, Chicago, p 60
Weinstein MC, Stason WB (1982) Cost-effectiveness of coronary artery bypass surgery. Circulation 66: 56–66
Welch HG, Larson EB (1989) Cost effectiveness of bone marrow transplantation in acute nonlymphocytic leukemia. N Engl J Med 321: 807–812
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Burhenne, L.J.W. (2000). Breast Cancer Screening: General Guidelines, Program Design, and Organization. In: Friedrich, M., Sickles, E.A. (eds) Radiological Diagnosis of Breast Diseases. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60919-0_20
Download citation
DOI: https://doi.org/10.1007/978-3-642-60919-0_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-66339-3
Online ISBN: 978-3-642-60919-0
eBook Packages: Springer Book Archive